Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease.
The matrix metalloproteinases (MMPs) are a unique family of metalloenzymes that, once activated, can destroy connective tissue. The active enzymes are all inhibited by tissue inhibitors of metalloproteinases (TIMPs). The relative amounts of active MMPs and TIMPs are important in determining whether tissues are broken down in disease. Although elastase is often regarded as the target enzyme in chronic obstructive pulmonary disease (COPD), both the neutrophils and macrophages in the lung contain metalloproteinases and both collagen and elastin are degraded in disease. Transgenic studies have shown that when MMP1 is over-expressed, pulmonary emphysema develops in mice, while MMP12 knockout mice do not develop pulmonary emphysema when exposed to cigarette smoke. New drugs that can specifically block active MMPs are now available. These potent inhibitors are effective in vitro and prevent the destruction of tissue in animal models. Future patient trials will test the effectiveness of these compounds in preventing tissue destruction.
Cawston
T
T
Department of Rheumatology, Department of Medicine, University of Newcastle, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Carrere
S
S
Catterall
J
J
Duggleby
R
R
Elliott
S
S
Shingleton
B
B
Rowan
A
A
D000818:Animals; D006801:Humans; D008171:Lung Diseases / Q000201:enzymology; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000201:enzymology; D020782:Matrix Metalloproteinases / Q000276:immunology* / Q000378:metabolism / Q000627:therapeutic use; D019714:Tissue Inhibitor of Metalloproteinases / Q000276:immunology* / Q000378:metabolism
D019714:Tissue Inhibitor of Metalloproteinases; D020782:Matrix Metalloproteinases